Stock Yearly Return 2015
Start date: 12/31/2014
End date: 12/31/2015
Start price/share: $0.40
End price/share: $3.28
Dividends collected/share: $0.00
Total return: 720.00%
Average Annual Total Return: 720.00%
Starting investment: $10,000.00
Ending investment: $82,000.00
Years: 1.00


NYMX average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare NYMX average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into NYMX


Also see:
NYMX stock yearly return 2016
NYMX stock yearly return 2017
NYMX stock yearly return 2018
NYMX stock yearly return 2019
NYMX stock yearly return 2020
NYMX YTD return
NYMX average annual return 10 years
Nymox Pharmaceutical is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia and the treatment of low-grade localized prostate cancer. Co. has developed and markets NicAlert™ and TobacAlert™, which is a test strips for determining whether a person is using tobacco products (NicAlert™) or has been exposed to second-hand smoke (TobacAlert™). The technology can be used with saliva as well as urine samples to detect tobacco product use. Co. also has developed AlzheimAlert™, a proprietary urine assay for the diagnosis of Alzheimer's disease. Co. has developed a kit version of the AlzheimAlert™ assay for sale in Europe. The NYMX stock yearly return is shown above.

The yearly return on the NYMX stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2015 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the NYMX annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for NYMX:
NYMX SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Nymox Pharmaceutical (NYMX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

OBLN Average Annual Return
OCUL Average Annual Return
OCX Average Annual Return
ODT Average Annual Return
OFIX Average Annual Return
OHRP Average Annual Return
OMED Average Annual Return
OMER Average Annual Return
OMI Average Annual Return
ONCE Average Annual Return
More Healthcare companies »

 

NYMX Stock Yearly Return 2015 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.